2m 2m 2m 2m 2m 2m 2m
Lantheus Holding (LNTH)
NASDAQ
$106.43+$0.39 (+0.37%)
Price as of Jun 23, 2026 7:58 PM EDT- $6.9BMarket Cap
- 31.42%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lantheus Holding (LNTH)
$106.43+$0.39 (+0.37%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.5B +0.50% | 1.5B +18.32% | 1.3B +38.65% | 935.1M +119.91% | |
Cost of Revenue | 599.7M +9.90% | 545.6M -7.03% | 586.9M +66.09% | 353.4M +48.77% | |
Gross Profit | 942.0M -4.69% | 988.3M +39.29% | 709.5M +21.98% | 581.7M +209.92% | |
Sales and Marketing Expense | 178.7M +0.42% | 177.9M +25.54% | 141.7M +41.39% | 100.2M +46.51% | |
Research and Development Expense | -177.3M +5.48% | -168.1M +116.32% | -77.7M -124.93% | 311.7M +593.15% | |
Depreciation and Amortization Expense | 70.1M +8.47% | 64.6M +7.63% | 60.0M +25.27% | 47.9M +13.34% | |
Total Operating Expenses | 599.7M +9.90% | 545.6M -7.03% | 586.9M +66.09% | 353.4M +48.77% | |
Operating Profit | 310.8M -31.98% | 457.0M +25.32% | 364.6M +907.44% | 36.2M +159.51% | |
Interest Income | 23.4M -36.50% | 36.8M +87.59% | 19.6M +651.55% | 2.6M +5,706.67% | |
Interest Expense | -15.1M 0.00% | -15.1M -24.57% | -20.0M +178.62% | -7.2M -7.31% | |
Interest Income and Expense and Net | 8.3M -61.86% | 21.7M +5,805.51% | -381,000 -105.30% | 7.2M -7.31% | |
Total Nonoperating Income and Expense | 31.3M -15.86% | 37.2M -43.86% | 66.3M +3,994.30% | -1.7M -76.83% | |
Income before Taxes | 313.8M -27.19% | 431.0M +4.88% | 410.9M +1,438.02% | 26.7M +135.61% | |
Income Taxes | 80.2M -32.31% | 118.5M +40.64% | 84.3M +6,352.37% | -1.3M -64.14% | |
Extraordinary Items | 0 N/A | 0 -100.00% | 138.1M N/A | N/A N/A | |
Net Income | 233.6M -25.25% | 312.4M -4.35% | 326.7M +1,063.86% | 28.1M +139.38% | |
Net Income from Continuing Operations Applicable to Common | 313.8M -27.19% | 431.0M +4.88% | 410.9M +1,438.02% | 26.7M +135.61% | |
Basic EPS and Net Income | 3.46 -23.45% | 4.52 -5.64% | 4.79 +1,068.29% | 0.41 +138.68% | |
Diluted EPS and Net Income | 3.41 -21.79% | 4.36 -6.24% | 4.65 +1,062.50% | 0.40 +137.74% | |
Basic Weighted Average Shares | 67.5M -2.47% | 69.2M +1.37% | 68.3M -0.32% | 68.5M +1.48% | |
Diluted Weighted Average Shares | 68.4M -4.48% | 71.7M +2.01% | 70.2M -0.61% | 70.7M +4.72% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 359.1M -60.66% | 912.8M +27.91% | 713.7M +71.70% | 415.7M +321.95% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 359.1M -60.66% | 912.8M +27.91% | 713.7M +71.70% | 415.7M +321.95% | |
Total Current Assets | 900.0M -32.16% | 1.3B +22.18% | 1.1B +60.24% | 677.6M +187.38% | |
Accumulated Depreciation | 72.8M -33.07% | 108.8M +1.62% | 107.0M +6.89% | 100.1M +12.61% | |
Property and Plant and Equipment and Net | 163.7M -7.42% | 176.8M +20.52% | 146.7M +20.08% | 122.2M +4.62% | |
Total Long-Term Assets | 50.0M +13.13% | 44.2M -19.95% | 55.3M +60.85% | 34.4M -11.36% | |
Total Assets | 2.2B +12.48% | 2.0B +19.94% | 1.7B +24.97% | 1.3B +52.96% | |
Income Taxes Payable | 54.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 738,000 -24.23% | 974,000 +18.35% | 823,000 +132.49% | 354,000 -96.96% | |
Total Current Liabilities | 333.4M +38.62% | 240.5M +28.38% | 187.3M -24.36% | 247.7M +173.71% | |
Total Long-Term Debt | 568.7M +0.60% | 565.3M +0.64% | 561.7M +0.71% | 557.7M +241.90% | |
Total Long-Term Liabilities | 107.9M +70.73% | 63.2M -0.22% | 63.3M +37.19% | 46.2M -63.04% | |
Total Liabilities | 1.1B +27.49% | 892.3M +6.83% | 835.3M -4.44% | 874.1M +118.89% | |
Retained Earnings | 679.5M +52.37% | 445.9M +234.03% | 133.5M +169.12% | -193.2M -12.69% | |
Total Stockholders Equity | 1.1B +0.16% | 1.1B +33.35% | 815.9M +82.47% | 447.1M -3.72% | |
Total Shares Outstanding | 64.6M -8.91% | 70.9M +1.49% | 69.9M +1.47% | 68.9M +1.64% | |
Cash Flow | |||||
Cash from Operating Activities | 390.1M -28.38% | 544.8M +78.45% | 305.3M +8.33% | 281.8M +422.63% | |
Capital Expenditures | 36.1M -30.09% | 51.6M +10.89% | 46.6M +153.75% | 18.3M +51.13% | |
Cash from Investing Activities | -627.2M +177.49% | -226.0M -3,905.61% | 5.9M +102.15% | -276.5M -7,608.74% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -316.6M +167.08% | -118.5M +807.49% | -13.1M -104.19% | 311.7M +892.46% | |
Financials Ratio | |||||
Gross Margin | 61.10% -5.16% | 64.43% +17.72% | 54.73% -12.02% | 62.21% +40.93% | |
Operating Margin | 20.16% -32.32% | 29.79% +5.92% | 28.13% +626.62% | 3.87% +127.06% | |
Return on Assets | 11.10% -35.48% | 17.21% -21.71% | 21.98% +755.57% | 2.57% +131.24% | |
Return on Equity | 21.45% -34.65% | 32.82% -36.55% | 51.73% +740.01% | 6.16% +142.27% | |
Revenue Growth | 0.50% -97.26% | 18.32% -52.60% | 38.65% -67.77% | 119.91% +374.34% | |
Current Ratio | 2.70 -51.06% | 5.52 -4.83% | 5.80 +111.86% | 2.74 +4.99% | |
Cash Ratio | 1.08 -71.62% | 3.80 -0.37% | 3.81 +127.01% | 1.68 +54.16% | |
Debt-to-Equity Ratio | 0.52 +0.40% | 0.52 -24.51% | 0.69 -44.76% | 1.25 +231.68% | |
Debt-to-Assets Ratio | 0.26 -10.60% | 0.29 -16.08% | 0.34 -19.34% | 0.42 +108.80% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow